Viewing Study NCT00671112


Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2025-12-26 @ 10:46 PM
Study NCT ID: NCT00671112
Status: TERMINATED
Last Update Posted: 2015-10-28
First Post: 2008-05-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma
Sponsor: Brian Hill, MD, PhD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module